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ABSTRACT
Background and the purpose of the study: The species Hymenocrater calycinus, belongs to the 
plant family Lamiaceae and grows wildly in the north-east of Iran. Previously, the antimicrobial 
activity of the plant extracts was reported. In the present study, the bioactivity-guided fractionation 
of the methanol extract of H. calycinus and the combination effects of the isolated compound 
with cell wall active agents against S. aureus and E. coli was investigated. 
Methods:  Column  and  thin  layer  chromatographic  methods  were  used  for  isolation  and 
purification and spectroscopic data (MS, 1H- and 13C-NMR, HMQC, HMBC and 1H-1H COSY) 
were employed for identification of the compound isolated from the extract. A disk diffusion 
method was used to determine the antibacterial activity of the isolated compound against S. 
aureus and E. coli in comparison with 7 different antibiotics.
Results: The isolated compound 1 was identified as 3-(3, 4- dihydroxyphenyl) lactic acid 2-O-quinic 
acid. Compound 1 (500 µg/disc) enhanced antibacterial effect of ampicillin, ciprofloxacin, 
vancomycin  and  cefepime  against  S.  aureus  and  activated    the  effects  of  ampicillin  and 
vancomycin against E. coli. 
Conclusion: Results showed that the compound 1 was not active against both tested strains at 
any concentration below 1 mg/disk, and as a result the enhancing effect of the compound could 
be due its association with antibiotics.
Keywords: Hymenocrater calycinus, Lamiaceae, 3-(3, 4- dihydroxyphenyl) lactic acid 2-O- quinic 
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INTRoDUCTIoN
Infectious  diseases  are  the  main  cause  of 
approximately  one-half  of  all  death  in  tropical 
countries (1). During the past decade life-threatening 
fungal  and  bacterial  infections  have  increased 
dramatically in immunocompromised patients (2). 
Among  the  microorganisms,  first  Esherichia  coli 
and  second  Staphylococcus  aureus  are  pathogens 
responsible  for  most  primary  and  secondary  skin 
infections. S.  aureus  is  also colonized in 30%  of 
burn wounds (3). In recent years, the resistance of 
these microorganisms to other antimicrobial agents 
have increased significantly (4).
Plants have provided a good source of novel anti-
infective compounds (5, 6). The first generation of 
the plant drugs were usually simple botanicals which 
were used in crude form and the second generation 
were the pure and active isolated molecules (1). 
In  the  search  for  potent  herbal  antimicrobial 
compound, the activity of an extract of Hymenocrater 
calycinus (Lamiaceae), which is growing wildly in the 
north east of Iran and some parts of Turkmania as an 
endemic plant and is called Gol-e-Arvaneh in Persian 
language, was investigated (7, 8). The synonym of 
this  plant  is  Hymenocrater  macrophyllum  Bunge 
(8) and there are several reports on the biological 
and phytochemical properties of this genus in the 
literatures  (9,  10).  Antibacterial  and  antifungal 
activity of the methanol extract of H. sessilifolius, 
by agar well diffusion and disk diffusion assays has 
also been reported previously (10). 
It has been found that the efficacy of antimicrobial 
agents  against  different  pathogens,  including  S. 
aureus, P. aeruginosa, and E. coli can be improved 
by combining with crude plant extracts (eg. Salvia 
officinalis) (11). 
This paper reports isolation and identification of an 
active compound from the methanol extract of 
H. calycinus, which is used traditionally in infectious 
diseases (10), by the bioactivity-guided fractionation 
and its antibacterial synergy with cell wall active 
antibiotics against S. aureus and E. coli. 
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University and another one housed at Herbarium of 
Medicinal Plants Research Center, Tehran University 
of  Medical Sciences. 
Extraction and isolation procedure 
The flowered aerial parts of H. calycinus (400 g) was 
cut into small pieces and percolated with methanol 
at  room  temperature  for  72  hrs.  Percolation  was 
repeated two more times. The MeOH extract (7.4 g) 
was successively subjected to reverse phase silica 
gel column chromatography with MeOH: H2O (4:6, 
7:3 and 1:0) to give five fractions (A-E). Fraction A 
(3.3 g) was further fractionated by a silica gel CC 
with AcOEt: MeOH (6:4) to yield five fractions 
(A1- A5). Compound 1 (35 mg) was obtained from 
A3 (0.5 g) using sephadex LH20 CC with MeOH. 
Evaluation of the combination effects of compound 1 
with different antibiotics 
A  disk  diffusion  method,  based  on  National 
Committee for Clinical Laboratory Standards (12), 
was  used  to  determine  the  activity  of  different 
antibiotics  and  compound  1  against  tested  strains 
(S. aureus, ATCC 29737 and E. coli, ATCC 8739) 
MATeRIAl   AND  MeThoDS
General experimental procedures 
1H-  and  13C-NMR  spectra  were  measured  on  a 
Brucker Avance 500 DRX (500 MHz for 1H and 125 
MHz for 13C) spectrometer with tetramethylsilane as 
an internal standard and chemical shifts are given 
in δ (ppm). EI-MS data were recorded on Agilent 
Technology (HP TM) instrument with 5973 Network 
Mass  Selective  Detector  (MS  model).  The  FT-IR 
spectra were recorded on a Nicolet 550 instrument. 
Silica  gel  60F254 pre-coated  plates  (Merck)  were 
used for TLC. The components were detected by 
spraying with anisaldehyde-H2SO4 reagent followed 
by heating.
Plant collection 
Aerial  parts  of  Hymenocrater  calycinus  (Boiss.) 
Benth.,  were  collected  from  Firuzkuh  near  to 
Delichaee  village, during flowering stage in July 
2005.  Two  Herbarium  specimens  were  identified 
by  Dr. Ali  Reza  Naghinejad  from  the  Faculty  of 
Sciences,  University  of  Tehran.  One  specimen 
was  deposited  at  Central  Herbarium  of  Tehran 
Table 1. The NMR data of the compound 1 in DMSO-d6.
h-hCoSY hMBC 1h- NMR (ppm) 13C- NMR (ppm) Carbon No.
H-5, H-7a, H-7b, H-8 132.2 1
H-6, H-7a, H-7b 6.65 (d, J= 1.6 Hz, 1H) 117.8 2
H-5 145.5 3
H-2, H-6 144.0 4
H-6 6.57 (d, J= 8.0 Hz, 1H) 116.0 5
H-5 H-2, H-7a, H-7b 6.44 (dd, J= 8.0, 1.6 Hz, 1H) 120.7 6
H-7b, H-8
H-7a, H-8
H-2, H-6, H-8
2.36 (dd, J= 13.8, 8.7 Hz, 1H)
2.84 (dd, J= 13.8, 2.8 Hz, 1H)
41.4 7
H-7a, H-7b H-7a     3.64 (dd, J= 8.7, 2.9 Hz, 1H) 73.5 8
  H-7a, H-7b, H-8 177.7 9
H-2′b, H-6′a, H-6′b 74.5 1’
H-2′b, H-3′
H-2′a, H-3′
1.51 (dd, J=12.1, 3.8 Hz, 1H)
1.61 (dd, J=12.1, 11.2 Hz, 1H)
40.7 2’
H-2′a, H-2′b, H-4′ H-2′b 3.93 (m, 1H) 67.2 3’
H-3′, H-5′ H-5′, H-3′ 3.41 (t, 1H)   74.2 4’
H-4′, H-6′a, H-6′b H-8, H-4′    3.57 (m, 1H) 69.8 5’
H-5′, H-6′b
H-5′, H-6′a
H-2′b  
1.45 (dd, J= 13.8, 3.5 Hz, 1H)
1.72  (dd, J= 13.8, 4.4 Hz, 1H)   
37.5 6’
H-2′b, H-6′a, H-6′b 180.3 7’A new quinic acid derivative  71
on Müeller-Hinton agar (Merck, Germany) plates. 
The standard antibiotics disks were supplied from 
Mast Co., UK. To determine the combination effect, 
each standard disc paper (ampicillin, ciprofloxacin, 
vancomycin,  cephalexine,  penicillin  G,  cefixime 
and  cefepime)  was  impregnated  with  the  tested 
compound  (500  µg). A  single  colony  of  the  test 
strains  were  grown  overnight  in  Müeller  -Hinton 
broth medium on a rotary shaker (200 rpm) at 35°C. 
The inocula were prepared by diluting the overnight 
cultures  with  0.9%  NaCl  to  a  0.5  McFarland 
standard and were applied to the plates along with 
the standard and prepared disks containing of tested 
compound (500µg/disc). Similar experiments were 
carried  out  with  isolated  compound  alone.  After 
incubation at 37°C for 24 hrs, the zones of inhibition 
were measured. Mean surface area of the inhibition 
zone (mm2) was calculated for each tested antibiotic 
from the mean diameter. The percentage of increase 
in the inhibition zone for different antibiotics were 
calculated as (b2-a2)/a2 × 100 where a and b are the 
inhibition zones A (antibiotic only) and B (antibiotic 
plus  compound 1 ),  respectively.  All  experiments 
were carried out in triplicates and standard deviations 
were negligible. 
ReSUlTS  AND  DISCUSSIoN
In this research, dried aerial parts of H. calycinus, 
was percolated with methanol to give 7.4 g of the 
extract (18.5% based on the dried weight of the plant 
sample).  The  extract  has  shown  antibacterial  and 
antifungal activity (13) and in this study one of its 
active components was isolated by the reverse phase 
silica  gel  and  sephadex  column  chromatography. 
The  isolated  compound  showed  a  pink  spot 
with  anisaldehyde-H2SO4  reagent  on  thin  layer 
chromatogram On the basis of physicochemical and 
spectral data its structure was established as 3-(3, 4- 
dihydroxyphenyl) lactic acid 2-O-quinic acid:
Pale yellow amorphous crystal; m. p. 160-161 °C; [α]
25 
-9.0° (c=0.003, MeOH); IR (CHCl3) νmax 3332, 2925, 
2229, 1731, 1605, 1445, 1228, 1073, 749 cm-1; EI-MS 
(70eV) m/z (%): 123 (100), 110 (42), 198 (18), 152 
(11); 1H and 13C-NMR spectra are shown in table 1.
Antibiotics (µg/disk)
   Inhibition zone against S. aureus Increase in the 
inhibition zone (%)
Antibiotic (A) Antibiotic + compound 1 (B)
Ampicillin (30) 23 28 48
Cefixime (5) 16 16 0
Ciprofloxacin (5) 19 21 22
Vancomycin (30) 12 14 36
Penicillin G (10UT) 24 24 0
Cefepime (30) 17 20 38
Cephalexine (30) 21 21 0
Table 2. Zone of inhibition (mm) of different antibiotics against S. aureus (in the absence and presence of compound 1 at concentration 
of 500 (µg/disk).
Antibiotics (µg/disk)
 Inhibition zone against E. coli
Increase in the 
inhibition zone (%)
Antibiotic (A) Antibiotic + compound 1 (B)
Ampicillin (30) 16 18 26
Cefixime (5) 0 0 0
Ciprofloxacin (5) 0 0 0
Vancomycin (30) 18 21 36
Penicillin G (10UT) 0 0 0
Cefepime (30) 31 31 0
Cephalexine (30) 22 22 0
Table 3. Zone of inhibition (mm) of different antibiotics against E. coli (in the absence and presence of compound 1 at concentration of 
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The  1H-NMR  spectrum  of  compound  1  exhibited 
aromatic ABX –type signals at 6.44 (dd, J= 8.0, 1.6 
Hz, 1H), 6.57 (d, J= 8.0 Hz, 1H) and  6.65 (d, J= 1.6 
Hz, 1H), assignable to H-6, 5 and 2, respectively. 
Aliphatic ABX-type signals at 2.36 (dd, J= 13.8, 
8.7 Hz, 1H), 2.84 (dd, J= 13.8, 2.8 Hz, 1H) and 
3.64 (dd, J= 8.7, 2.9 Hz, 1H) are assignable to H-7, 
H-7' and H-8 of 3, 4- dihydroxyphenyl- lactic acid 
part of the compound 1 respectively. The 13C NMR 
data revealed the presence of a quinic acid moiety 
characterized with two methylenes (δ 37.5 and 40.7), 
three  oxymethines  (δ  67.2,  69.8,  and  74.2),  one 
quaternary carbon (δ 74.5), and one carboxyl group 
(δ 180.3), as well as a 3, 4- dihydroxyphenyl- lactic 
acid  moiety  characterized    by  6  aromatic  carbon 
(δ 116.0 - 145.5, C-1 to C-6), one methylene at δ 
41.4(C-7), one oxygenated CH at δ 73.0 (C-8), and 
one carboxylic acid at δ 177.7 (C-9). 
The OH group of the position of 5’ of quinic acid unit 
is connected (via etheric linkage) to the C-8 of the 3, 
4- dihydroxyphenyl- lactic acid based on the HMBC 
correlations (see Table 1). The molecular formula, 
C16H20O10,  revealed  the  structure  of  compound  1 as 
3-(3, 4- dihydroxyphenyl) lactic acid 2-O-quinic acid.
While,  many  esters  of  quinic  acid  have  been 
identified as bioactive natural compounds (14), the 
compound of this study is considered to be a new 
phenylpropanoid  derivative  of  quinic  acid  which 
has  not  been  reported  previously.  Antibacterial 
assays indicated that the compound 1 did not show 
any activity at the tested concentrations (125, 250 
and 500 µg/disc), however, this compound (500µg/
disc)  enhanced  the  activity  of  several  antibiotics 
against S. aureus and E. coli (Tables 2, 3). Ampicillin, 
ciprofloxacin,  vancomycin  and  cefepime  caused 
48%, 22%, 36% and 38% increase in the inhibition 
zone  of  surface  area  of  the  compound  1  against  S. 
aureus respectively. Also, ampicillin and vancomycin 
represented 26% and 36% fold increase in the surface 
area of inhibition zone of compound 1 against E. coli. 
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Fig 1. Chemical structure of the isolated compound 1 from 
H. calycinus  and  H-H COSY  correlations  (bold  bands).
Fig 2. HMBC correlations of compound 1 (H    C).
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